Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.40 Analyst target: $8.25 Upside: 489.29%
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapies for the treatment of serious diseases with unmet medical needs in the United States. The company is headquartered in La Jolla, California.
See the full interactive analysis & chart →Informational only — not investment advice.